coagulation Flashcards

1
Q

ability of the blood stop bleeding

A

hemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

wall defect in endothelial causes what to factors to be exposed

A

collagen
von willebrand factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

formation of a clot term

A

thrombogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

red thrombus

A

veins

RBC
long fibrin tail
detach -> PE/DVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

white thrombus

A

arterial flow

platelets and fibrin cross-linking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

glycoproteins on platelet cell surfaces

name and what they bind to

A

collegen binds to glycoprotein 1a receptor

vWF binds to glycoprotein 1b receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 soluble mediators in platelet activation

A

adenosine (ADP)
thromboxane A2
serotonin (5HT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what do NSAIDS inhibit

A

prostaglandin synthesis

  • pro-clot
  • black box for CV events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does aspirin target

A

inhibits thromboxane A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what do endothelial cells normally produce

A

prostaglandin I2 (prostacyclin)

inhibits platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

extrinsic pathway activation

A

outside tissue damage exposes tissue factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

intrinsic pathway activation

A

inside the vessel

platelets interact with damaged endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DVT Virchow’s Triad

A
  1. stasis
  2. hyper coagulability
  3. endothelial injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

inherited DVT risk factors

A

antithrombin III deficiency (normally inhibits thrombin from forming)

Protein C and S deficiency (inhibit factor 8)

sickle cell anemia (RBC become trapped and damage endothelium)

activated protein C resistance (normal amount of protein C but factors produced are resistant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

acquired DVT risk factors

A

bedbound, surgery, trauma, obesity, estrogen malignancies, chronic venous insufficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DIC

what is it

A

disseminated intervascular coagulation

  • using up all clotting factors and platelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what causes DIC

A
  • gram (-) bacteria b/c of endotoxins it releases
  • massive tissue injury
  • malignancy
  • abruptio placentae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

protease inhibitors

what they do?
list 4 of them

A

inactivate the coagulation proteins

alpha 1 antiprotease
alpha 2 macroglobulin
alpha 2 antiplasmin
antithrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what breaks down the clot after its formed?

A

inactive plasminogen -> plasmin

activated by tissue plasminogen activator (tPA)

  • plasmin breaks down the fibrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

intrinsic pathway numbers

A

12, 11, 9, 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

extrinsic pathway numbers

A

7, 10

22
Q

common pathway

A

prothrombin -> thrombin
fibrinogen -> fibrin

23
Q

what factors does thrombin activate? (5)

A

factor 13
factor 5
factor 8
factor 11
protein C

24
Q

hemophilia type A is what clotting factor

A

8

25
Q

3 activators of plasminogen -> plasmin

fibrinolytics

A
  • pro-bleeding
  • catalyze formation of serine protease plasmin
  • tissue plasminogen activator (tPA)
  • Urokinase
  • Streptokinase
26
Q

what makes up anistreplase

A

pro-activator + streptokinase

= activator

27
Q

2 drugs protect clots from lysis

inhibit plasminogen -> plasmin

A

aminocaproic acid
TXA

28
Q

HIT
what is it?
treatment?

A

antibodies target thrombocytes (decrease platelets)

stop drug
platlets, FFP

7-10 days post initiation

29
Q

aptt

A

activated partial thromboplastin time

35-45 seconds

intrinsic and common pathway

phospholipid added to induce intrinsic pathway

30
Q

PT

A

prothrombin time

extrinsic and common pathway

addition of tissue factor 3

time to clot compared to control (INR)

31
Q

INR

A

warfarin 2-3

32
Q

3 indirect thrombin inhibitors

A

enhances antithrombin

HMWH: antithrombin 3 (Xa and thrombin)

LMWH: factor Xa

Fondaparinux: antithrombin

33
Q

heparin reversal

how does it work?

A

protamine

(+) binds to heparin (-)

34
Q

what complex do indirect thrombin inhibitors have?

A

pantasaccharide

HMWH, LMWH, fondaparinux

35
Q

direct thrombin inhibitors (3)

A

argatroban
dabigatran
Hirudin (lab version)

36
Q

warfarin MOA

A

blocks gamma carboxylation of several glutamate resides (clotting factors 2,7,9,10) thrombin
- vit K dependent
- oxidation and reduction reaction
- high protein binding

37
Q

warfarin reversal

A

stop drug
vit K
FFP
factor 9

38
Q

heparin toxicity (3)

A

hemorrhagic disorder of fetus

birth defects

cutaneous necrosis

39
Q

factor 10a inhibitors (2)

A

rivaroxaban
apixaban

40
Q

streptokinase

A

fibrinolytic
plasminogen -> plasmin

streptococci bacteria

41
Q

urokinase

A

fibrinolytic
plasminogen -> plasmin

synthesized by kidney and synthetic version

42
Q

t-PA

A

tissue plasminogen activator

fibrinolytic

alteplase

activates plasminogen that it bound to fibrin -> plasmin

43
Q

aspirin

A

cox 1
inhibits TXA2 synthesis

44
Q

plavix

A

irreversibly inhibit ADP receptors on platelets

45
Q

abciximab

A

2B and 3A glycoreceptors blockers

antiplatelet

monoclonial antibody

46
Q

vit K

A

green leafy vegetables

activity on prothrombin, factors 7,9,10

47
Q

desmopressin

A

increase factor 8

tx: von willebrand, hemophilliaA

48
Q

aminocaproic acid

A

competitively inhibits plasminogen activation

49
Q

tranexamic acid

A

TXA
antifibrinolytic
inhibits plasminogen
TX: severe bleeding

50
Q

what does fibrin bind to on the platelets

A

glycoprotein 2b and 3a